<?xml version="1.0" encoding="UTF-8"?>
<p id="p0260">The increasing number of people suffering from virus diseases requires the development of new and effective methods of treatment. Two main approaches are considered in the field. The first longer approach is based on developing anti-viral drug 
 <italic>de-novo</italic> in opposite to the second approach, which is based on drug repositioning or drug repurposing. In the second case, the safety data and needed assays are already in place, so it may save a year of new drug development (
 <xref rid="bib42" ref-type="bibr">Mani et al., 2019</xref>). In the case of antipsychotic drugs such as phenothiazine derivatives, the novel antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine were observed and confirmed by several research groups toward different types of viruses, both 
 <italic>in vitro</italic> and 
 <italic>in vivo</italic>.
</p>
